BiomX raised €22M in a Series A round in May 2017. The company is based in Ness Ziona, Israel. Investors in the round: Innovation SBI Japan-Israel Innovation Fund, Johnson & Johnson, Mirae Asset Venture Investment and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
